| Genomic portrait of resectable hepatocellular carcinomas: Implications of RB1 and FGF19 aberrations for patient stratification SM Ahn, SJ Jang, JH Shim, D Kim, SM Hong, CO Sung, D Baek, F Haq, ... Hepatology 60 (6), 1972-1982, 2014 | 419 | 2014 |
| General rules for functional microRNA targeting D Kim, YM Sung, J Park, S Kim, J Kim, J Park, H Ha, JY Bae, SH Kim, ... Nature genetics 48 (12), 1517-1526, 2016 | 144 | 2016 |
| A high-resolution temporal atlas of the SARS-CoV-2 translatome and transcriptome D Kim, S Kim, J Park, HR Chang, J Chang, J Ahn, H Park, J Park, N Son, ... Nature communications 12 (1), 5120, 2021 | 60 | 2021 |
| The regulatory impact of RNA-binding proteins on microRNA targeting S Kim, S Kim, HR Chang, D Kim, J Park, N Son, J Park, M Yoon, G Chae, ... Nature communications 12 (1), 5057, 2021 | 58 | 2021 |
| Genomic alterations in the RB pathway indicate prognostic outcomes of early-stage lung adenocarcinoma S Choi, HR Kim, CO Sung, J Kim, S Kim, SM Ahn, C Choi, SM Chun, ... Clinical Cancer Research 21 (11), 2613-2623, 2015 | 21 | 2015 |
| Phase II study of a trastuzumab biosimilar in combination with paclitaxel for HER2-positive recurrent or metastatic urothelial carcinoma: KCSG GU18-18 M Kim, JL Lee, SJ Shin, WK Bae, HJ Lee, JH Byun, YJ Choi, J Youk, ... ESMO open 8 (4), 101588, 2023 | 3 | 2023 |
| Papillary thyroid cancer immune phenotypes via tumor-infiltrating lymphocyte spatial analysis M Nam, W Yang, HS Kim, J Park, G Park, S Kim, S Song, CY Ock, ... Endocrine-related cancer 30 (9), 2023 | 1 | 2023 |
| Performance validation of an artificial intelligence-powered PD-L1 combined positive score analyzer in six cancer types. T Lee, SI Cho, S Choi, S Kim, W Jung, D Lee, S Lee, M Mostafavi, S Park, ... Journal of Clinical Oncology 41 (16_suppl), e13553-e13553, 2023 | 1 | 2023 |
| Correlation of fragmented pattern of tumor mass captured by artificial intelligence (AI)-powered whole-slide image (WSI) analysis with biased fibroblast expansion over tumor … S Kim, S Song, G Park, S Kim, H Song, M Kang, S Pereira, CY Ock Journal of Clinical Oncology 41 (16_suppl), e14657-e14657, 2023 | 1 | 2023 |
| 1285 Spatial analysis of tumor-infiltrating lymphocytes (TILs) based on HER2 expression across multiple cancer types S Kim, S Kim, Y Lim, G Park, S Song, H Song, S Park, J Ryu, S Pereira, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | 1 | 2022 |
| A phase II open-label randomized clinical trial of preoperative durvalumab or durvalumab plus tremelimumab in resectable head and neck squamous cell carcinoma CG Kim, MH Hong, D Kim, BH Lee, H Kim, CY Ock, G Kelly, YJ Bang, ... Clinical Cancer Research, OF1-OF14, 2024 | | 2024 |
| An artificial intelligence‐powered PD‐L1 combined positive score (CPS) analyser in urothelial carcinoma alleviating interobserver and intersite variability KS Lee, E Choi, SI Cho, S Park, J Ryu, AV Puche, M Ma, J Park, W Jung, ... Histopathology, 2024 | | 2024 |
| Inflamed immune phenotype predicts favorable clinical outcomes of immune checkpoint inhibitor therapy across multiple cancer types J Shen, YL Choi, T Lee, H Kim, YK Chae, BW Dulken, S Bogdan, ... Journal for Immunotherapy of Cancer 12 (2), 2024 | | 2024 |
| Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes for prediction of prognosis in resected colon cancer Y Lim, S Choi, HJ Oh, C Kim, S Song, S Kim, H Song, S Park, JW Kim, ... NPJ Precision Oncology 7 (1), 124, 2023 | | 2023 |
| 1293 Fragmented pattern of tumor mass is related to fibroblast activation mitigating spatial interaction between tumor and immune cells S Kim, S Song, S Kim, M Kang, M Mostafavi, D Yoo, CH Ahn, S Ali, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| Artificial intelligence‐powered spatial analysis of tumor‐infiltrating lymphocytes as a biomarker in locally advanced unresectable thymic epithelial neoplasm: A single‐center … DH Kim, Y Lim, S Kim, CY Ock, J Youk, M Kim, TM Kim, DW Kim, HJ Kim, ... Thoracic Cancer 14 (30), 3001-3011, 2023 | | 2023 |
| Artificial intelligence (AI)–powered spatial analysis of macrophages in tumor microenvironment and its association with interferon-gamma (IFNG) signature and immune phenotype … C Oum, G Park, H Song, J Lee, S Pereira, S Song, S Kim, W Jung, CY Ock Journal of Clinical Oncology 41 (16_suppl), 2621-2621, 2023 | | 2023 |
| Artificial intelligence (AI) analysis of tumor-infiltrating lymphocytes (TILs) in hematoxylin and eosin (H&E) slides to explore immune phenotypes in papillary thyroid cancer. M Nam, LIY Chung, L Kim, G Park, S Kim, S Song, CY Ock, YK Chae Journal of Clinical Oncology 41 (16_suppl), 6100-6100, 2023 | | 2023 |
| Effect of an artificial intelligence–powered programmed death-ligand 1 combined positive score analyzer in urothelial cancer on inter-observer and inter-site variability. SI Cho, JH Park, KS Lee, E Choi, W Jung, S Song, S Kim, J Shin, J Ryu, ... Journal of Clinical Oncology 41 (16_suppl), e13546-e13546, 2023 | | 2023 |
| Deep learning-based ensemble model using H&E images for the prediction of KRAS G12C mutations in non-small cell lung cancer S Park, J Park, M Ma, HA Jung, JM Sun, YL Choi, JS Ahn, MJ Ahn, S Song, ... Cancer Research 83 (7_Supplement), 5399-5399, 2023 | | 2023 |
Doyeon KimIllumina Artificial Intelligence LaboratoryVerified email at illumina.com
